Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension

Cannabidiol (CBD) is a plant-derived compound with antioxidant and anti-inflammatory properties. Pulmonary hypertension (PH) is still an incurable disease. CBD has been suggested to ameliorate monocrotaline (MCT)-induced PH, including reduction in right ventricular systolic pressure (RVSP), a vasore...

Full description

Bibliographic Details
Main Authors: Anna Krzyżewska, Marta Baranowska-Kuczko, Anna Jastrząb, Irena Kasacka, Hanna Kozłowska
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/10/3327
_version_ 1797497461294497792
author Anna Krzyżewska
Marta Baranowska-Kuczko
Anna Jastrząb
Irena Kasacka
Hanna Kozłowska
author_facet Anna Krzyżewska
Marta Baranowska-Kuczko
Anna Jastrząb
Irena Kasacka
Hanna Kozłowska
author_sort Anna Krzyżewska
collection DOAJ
description Cannabidiol (CBD) is a plant-derived compound with antioxidant and anti-inflammatory properties. Pulmonary hypertension (PH) is still an incurable disease. CBD has been suggested to ameliorate monocrotaline (MCT)-induced PH, including reduction in right ventricular systolic pressure (RVSP), a vasorelaxant effect on pulmonary arteries and a decrease in the white blood cell count. The aim of our study was to investigate the effect of chronic administration of CBD (10 mg/kg daily for 21 days) on the parameters of oxidative stress and inflammation in the lungs of rats with MCT-induced PH. In MCT-induced PH, we found a decrease in total antioxidant capacity (TAC) and glutathione level (GSH), an increase in inflammatory parameters, e.g., tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), nuclear factor kappa B (NF-κB), monocyte chemoattractant protein-1 (MCP-1), and cluster of differentiation 68 (CD68), and the overexpression of cannabinoid receptors type 1 and 2 (CB<sub>1</sub>-Rs, CB<sub>2</sub>-Rs). Administration of CBD increased TAC and GSH concentrations, glutathione reductase (GSR) activity, and decreased CB<sub>1</sub>-Rs expression and levels of inflammatory mediators such as TNF-α, IL -1β, NF-κB, MCP-1 and CD68. In conclusion, CBD has antioxidant and anti-inflammatory effects in MCT-induced PH. CBD may act as an adjuvant therapy for PH, but further detailed preclinical and clinical studies are recommended to confirm our promising results.
first_indexed 2024-03-10T03:18:35Z
format Article
id doaj.art-b7f17727a5274495b62549b5000f3188
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-10T03:18:35Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-b7f17727a5274495b62549b5000f31882023-11-23T12:24:41ZengMDPI AGMolecules1420-30492022-05-012710332710.3390/molecules27103327Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary HypertensionAnna Krzyżewska0Marta Baranowska-Kuczko1Anna Jastrząb2Irena Kasacka3Hanna Kozłowska4Department of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Mickiewicz 2A, 15-222 Bialystok, PolandDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Mickiewicz 2A, 15-222 Bialystok, PolandDepartment of Analytical Chemistry, Medical University of Bialystok, Mickiewicz 2D, 15-222 Bialystok, PolandDepartment of Histology and Cytophysiology, Medical University of Bialystok, Mickiewicz 2C, 15-222 Bialystok, PolandDepartment of Experimental Physiology and Pathophysiology, Medical University of Bialystok, Mickiewicz 2A, 15-222 Bialystok, PolandCannabidiol (CBD) is a plant-derived compound with antioxidant and anti-inflammatory properties. Pulmonary hypertension (PH) is still an incurable disease. CBD has been suggested to ameliorate monocrotaline (MCT)-induced PH, including reduction in right ventricular systolic pressure (RVSP), a vasorelaxant effect on pulmonary arteries and a decrease in the white blood cell count. The aim of our study was to investigate the effect of chronic administration of CBD (10 mg/kg daily for 21 days) on the parameters of oxidative stress and inflammation in the lungs of rats with MCT-induced PH. In MCT-induced PH, we found a decrease in total antioxidant capacity (TAC) and glutathione level (GSH), an increase in inflammatory parameters, e.g., tumor necrosis factor alpha (TNF-α), interleukin-1β (IL-1β), nuclear factor kappa B (NF-κB), monocyte chemoattractant protein-1 (MCP-1), and cluster of differentiation 68 (CD68), and the overexpression of cannabinoid receptors type 1 and 2 (CB<sub>1</sub>-Rs, CB<sub>2</sub>-Rs). Administration of CBD increased TAC and GSH concentrations, glutathione reductase (GSR) activity, and decreased CB<sub>1</sub>-Rs expression and levels of inflammatory mediators such as TNF-α, IL -1β, NF-κB, MCP-1 and CD68. In conclusion, CBD has antioxidant and anti-inflammatory effects in MCT-induced PH. CBD may act as an adjuvant therapy for PH, but further detailed preclinical and clinical studies are recommended to confirm our promising results.https://www.mdpi.com/1420-3049/27/10/3327pulmonary hypertensioncannabidioloxidative stressinflammationmonocrotaline
spellingShingle Anna Krzyżewska
Marta Baranowska-Kuczko
Anna Jastrząb
Irena Kasacka
Hanna Kozłowska
Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
Molecules
pulmonary hypertension
cannabidiol
oxidative stress
inflammation
monocrotaline
title Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
title_full Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
title_fullStr Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
title_full_unstemmed Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
title_short Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension
title_sort cannabidiol improves antioxidant capacity and reduces inflammation in the lungs of rats with monocrotaline induced pulmonary hypertension
topic pulmonary hypertension
cannabidiol
oxidative stress
inflammation
monocrotaline
url https://www.mdpi.com/1420-3049/27/10/3327
work_keys_str_mv AT annakrzyzewska cannabidiolimprovesantioxidantcapacityandreducesinflammationinthelungsofratswithmonocrotalineinducedpulmonaryhypertension
AT martabaranowskakuczko cannabidiolimprovesantioxidantcapacityandreducesinflammationinthelungsofratswithmonocrotalineinducedpulmonaryhypertension
AT annajastrzab cannabidiolimprovesantioxidantcapacityandreducesinflammationinthelungsofratswithmonocrotalineinducedpulmonaryhypertension
AT irenakasacka cannabidiolimprovesantioxidantcapacityandreducesinflammationinthelungsofratswithmonocrotalineinducedpulmonaryhypertension
AT hannakozłowska cannabidiolimprovesantioxidantcapacityandreducesinflammationinthelungsofratswithmonocrotalineinducedpulmonaryhypertension